Effect of a Phosphate Modified Diet on Phosphate Balance and Phosphate Metabolism in Predialysis Patients Stage 3-4
1 other identifier
interventional
24
1 country
1
Brief Summary
Patients with chronic kidney disease struggle to eliminate phosphate as the renal function deteriorates, which results in accumulation of phosphate in the body. This has been shown to increase the patients' risk of cardiovascular disease and death. Even with dialysis treatment the patients cannot excrete enough phosphate to reach phosphate balance. The patients are therefore recommended a very restrictive diet when they reach the dialysis stage. It is therefore important to find ways to prevent such accumulation of phosphate in the body as early in the disease process as possible, but without compromising the nutritional status. Because phosphate occurs naturally in many of our foods, such as meat, fish and dairy products, it is difficult to reduce the intake of phosphate, without also reducing the intake of energy and protein. Over the past couple of years there has been an increased focus on the use of phosphate containing additives in the food industry. A reduction in the intake of phosphorus containing additives may reduce the accumulation of phosphate in the body. This can be achieved by decreasing the intake of processed food products. Because it is also very time consuming and inconvenient for the patient to keep these strict diets, the patients have a reasonable claim to know which effects can be achieved by such diets. This will therefore seek to be further explored in the following study. The study is conducted as a randomised crossover trial in predialysis patients stage 3-4.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 25, 2014
CompletedFirst Posted
Study publicly available on registry
February 27, 2014
CompletedStudy Start
First participant enrolled
March 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedJuly 18, 2014
July 1, 2014
4 months
February 25, 2014
July 17, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Phosphate balance
1 week
Secondary Outcomes (7)
p-phosphate
1 week
p-PTH
1 week
p-Calcium
1 week
FGF23
1 week
p-25(OH)D
1 week
- +2 more secondary outcomes
Study Arms (1)
Phosphate modified diet
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Patients \> 18 years.
- Diagnosed with Chronic Kidney Disease stage 3-4 (GFR 15-59 ml / min)
- p-phosphate between 0.85 mmol / L (2.7 mg / dL) and 1.50 mmol / L (4.7 mg / dl)
- Read and understand Danish
- Have received oral and written information about the study
- Signed informed consent form
You may not qualify if:
- Diagnosed hyperphosphatemia
- Diagnosed hyperparathyroidism
- Treatment with phosphate binders
- Dysphagia
- Diagnosed with decreased absorption capacity in the intestine
- Co-morbidities in liver, pancreas or lungs
- Dementia
- Pregnancy / breastfeeding
- Embedded within the last 4 weeks
- Kidney transplant
- Terminal patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Copenhagenlead
- Camilla Storm Slumstrupcollaborator
- Ewa Lewincollaborator
- Casper Rydahlcollaborator
Study Sites (1)
Herlev Hospital
Herlev, Herlev Ringvej 75, 2730, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jens R Andersen, MD, MPA
University of Copenhagen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor at the University of Copenhagen
Study Record Dates
First Submitted
February 25, 2014
First Posted
February 27, 2014
Study Start
March 1, 2014
Primary Completion
July 1, 2014
Study Completion
July 1, 2014
Last Updated
July 18, 2014
Record last verified: 2014-07